ES2040205T3 - Procedimiento para la obtencion de alfa-hidroxitioeteres. - Google Patents

Procedimiento para la obtencion de alfa-hidroxitioeteres.

Info

Publication number
ES2040205T3
ES2040205T3 ES198686116810T ES86116810T ES2040205T3 ES 2040205 T3 ES2040205 T3 ES 2040205T3 ES 198686116810 T ES198686116810 T ES 198686116810T ES 86116810 T ES86116810 T ES 86116810T ES 2040205 T3 ES2040205 T3 ES 2040205T3
Authority
ES
Spain
Prior art keywords
single bond
group
optionally
phenylene
ethylene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198686116810T
Other languages
English (en)
Inventor
Andreas Dr. Beck
Werner Dr. Breitenstein
Andreas Dr. Von Sprecher
Robert Werner Dr. Lang
Konrad Dr. Oertle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Application granted granted Critical
Publication of ES2040205T3 publication Critical patent/ES2040205T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Saccharide Compounds (AREA)

Abstract

NUEVOS TIOETERES ASIMETRICOS, DE FORMULA DONDE LOS SIMBOLOS GENERALES TIENEN EL SIGNIFICADO SIGUIENTE: A ES UNA CIFRA ENTERA DE 1 A 7; R0 ES HIDROGENO O C1 POR UN GRUPO HIDROXILO LIBRE O ACILADO, UN HALOGENO CON NUMERO ATOMICO HASTA 17 O POR METOXILO, O C1 ES UN RESTO, DADO EL CASO INSATURADO, ALIFATICO, CON 5-15 ATOMOS DE C, A ES ETILENO O TAMBIEN, EN CASO DE QUE R1 SEA UN RESTO HALOGENADO Y/O B SEA FENILENO O ETILENO, EQUIVALE A UN ENLACE SENCILLO O VINILENO; B ES UN ENLACE SENCILLO, ETINILENO O FENILENO; R3 ES UN HIDROXILO, C1 DADO EL CASO SUSTITUIDO; Y X ES UN ENLACE SENCILLO, UN GRUPO METILENO O UN GRUPO AMINOMETILENO, DADO EL CASO N MARIO, Y SUS SALES SON ACTIVAS COMO ANTAGONISTAS DE LOS LEUCOTRIENOS, EN EL QUE ELLOS ELIMINAN LAS CONTRACCIONES DE LOS MUSCULOS LISOS SUSCITADAS POR LOS LEUCOTRIENOS Y SON ADECUADOS, POR LO TANTO, PARA EL TRATAMIENTO DE ESTADOS ALERGICOS, SOBRE TODO LOS ASMATICOS.
ES198686116810T 1985-12-06 1986-12-03 Procedimiento para la obtencion de alfa-hidroxitioeteres. Expired - Lifetime ES2040205T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH522885 1985-12-06

Publications (1)

Publication Number Publication Date
ES2040205T3 true ES2040205T3 (es) 1993-10-16

Family

ID=4290092

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198686116810T Expired - Lifetime ES2040205T3 (es) 1985-12-06 1986-12-03 Procedimiento para la obtencion de alfa-hidroxitioeteres.

Country Status (17)

Country Link
US (1) US4808572A (es)
EP (1) EP0225602B1 (es)
JP (1) JPS62138465A (es)
AT (1) ATE68177T1 (es)
AU (1) AU6613886A (es)
CA (1) CA1303294C (es)
DD (1) DD260494A5 (es)
DE (1) DE3681890D1 (es)
DK (1) DK586186A (es)
ES (1) ES2040205T3 (es)
FI (1) FI864901A (es)
GR (1) GR3003066T3 (es)
HU (1) HU196173B (es)
IL (1) IL80866A0 (es)
NO (1) NO864896L (es)
PT (1) PT83868B (es)
ZA (1) ZA869213B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5149717A (en) * 1988-03-29 1992-09-22 Ciba-Geigy Corporation Alkanophenones useful for treating allergies
FR2648814B1 (fr) * 1989-06-26 1991-10-18 Lafon Labor L'alpha (tert-butyl-aminomethyl-3,4-dichlorobenzyl)thioacetamide, son procede de preparation et son application en therapeutique
EP0419410A3 (en) * 1989-09-19 1991-08-14 Ciba-Geigy Ag Alkanophenones
EP0608760B1 (de) * 1993-01-29 2004-09-15 Ticona GmbH Faserverstärktes Cycloolefincopolymer-Material, Verfahren zu seiner Herstellung und Formkörper aus dem Material
WO2005047230A1 (en) * 2003-11-13 2005-05-26 The University Of Sydney Bis-cationic compounds and use thereof
WO2007022718A1 (en) * 2005-08-25 2007-03-01 Chunde Liu Alkyl aryl alkyl alcohols, their derivations and preparation process thereof
CN103313964A (zh) 2010-10-28 2013-09-18 Mapi医药公司 用于制备芬戈莫德的中间化合物和方法
CN102850319A (zh) * 2011-06-27 2013-01-02 中国药科大学 一种制备{5-[2-(4-正辛基苯基)乙基]-2,2-二甲基-1,3-二氧六环-5-基}氨基甲酸叔丁酯的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3262587D1 (en) * 1981-03-03 1985-04-25 Lilly Industries Ltd Leukotriene analogues, their preparation and use in pharmaceutical compositions
US4513005A (en) * 1981-06-18 1985-04-23 Lilly Industries Limited SRS-A antagonists
US4461775A (en) * 1982-08-02 1984-07-24 Mcneilab, Inc. Hydroxythioether fatty acid derivatives
DK130984A (da) * 1983-03-07 1984-09-08 Smithkline Beckman Corp Leukotrien-antagonister
US4533747A (en) * 1983-03-07 1985-08-06 Smithkline Beckman Corporation Leukotriene antagonists intermediates
US4552893A (en) * 1983-03-07 1985-11-12 Smithkline Beckman Corporation Leukotriene antagonists
DE3469169D1 (en) * 1983-04-21 1988-03-10 Merck Frosst Canada Inc Leukotriene antagonists, their production and use and compositions containing them
DE3582527D1 (en) * 1984-06-28 1991-05-23 Ciba Geigy Ag Aliphatische thioether.

Also Published As

Publication number Publication date
NO864896D0 (no) 1986-12-05
PT83868B (pt) 1989-07-31
FI864901A (fi) 1987-06-07
DD260494A5 (de) 1988-09-28
US4808572A (en) 1989-02-28
ZA869213B (en) 1987-07-29
DK586186D0 (da) 1986-12-05
FI864901A0 (fi) 1986-12-01
EP0225602B1 (de) 1991-10-09
CA1303294C (en) 1992-06-09
NO864896L (no) 1987-06-09
EP0225602A2 (de) 1987-06-16
GR3003066T3 (en) 1993-02-17
DK586186A (da) 1987-06-07
JPS62138465A (ja) 1987-06-22
PT83868A (en) 1987-01-01
HUT43560A (en) 1987-11-30
DE3681890D1 (en) 1991-11-14
IL80866A0 (en) 1987-03-31
ATE68177T1 (de) 1991-10-15
EP0225602A3 (en) 1989-06-14
AU6613886A (en) 1987-06-11
HU196173B (en) 1988-10-28

Similar Documents

Publication Publication Date Title
ES2044834T3 (es) Procedimiento para la obtencion de tioeteres aromaticos.
SE8302130L (sv) Farmakologiskt aktiva bifosfonater, forfarande for deras framstellning och farmaceutiska kompositioner innehallande desamma
RU97106329A (ru) Иодированные рентгеноконтрастные средства
IE822322L (en) Vicinal dihydroxyalkylxanthines
ES2040205T3 (es) Procedimiento para la obtencion de alfa-hidroxitioeteres.
ES8405796A1 (es) Procedimiento de preparacion de benzoazacicloalquil-espiroimidazolidina, asi como de sus sales obtenidas con bases minerales u organicas farmaceuticamente aceptables.
DK294883A (da) Fremgangsmaade til fremstilling af alfa-alkylpolyolefincarboxylsyrer
ES519532A0 (es) Procedimiento de preparacion de derivados de imidazolidina.
ES523389A0 (es) Procedimiento para la fabricacion de derivados de indolicina.
ES539656A0 (es) Un procedimiento para la preparacion de nuevas 3-alcoxi-2-(n-pirrolidino)-n-piridiln-furilmetil propilaminas.
GB2001066A (en) Preparation of benzylidene derivatives
FI873365A (fi) Foerfarande foer framstaellning av nya fosfo-foereningar.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 225602

Country of ref document: ES